Statement by Blue Earth Diagnostics on COVID-19 click here for more information

Blue Earth Diagnostics Board

Our Directors come from a wide-range of relevant backgrounds and make an active contribution to company strategy.


Board Members

Chief Executive Officer at Bracco Imaging

Fulvio Renoldi Bracco

Fulvio Renoldi Bracco holds a degree in Economics from “Bocconi” University in Milan where he graduated with a final dissertation based on US and EU regulations on Mergers and Acquisitions.

He subsequently spent four years in Citibank in London, New York and Milan where he finally specialized in structured finance products for the financial institution industry.

Since 1996, he joined his family in the management of Bracco S.p.A., where he initially worked in the corporate Finance Department.

In 2002 he became Chairman and CEO of Acist, a US Affiliate of the Bracco Group, specialized in the development manufacturing and marketing of proprietary cutting edge medical systems.

In April 2009 he became the head of the Global Business Unit Imaging of Bracco Imaging S.p.A., one of the World’s leading companies in the diagnostic imaging business. Part of Bracco S.p.A., the holding company of Bracco Group, Bracco Imaging operates in over 90 markets worldwide, either directly or indirectly through subsidiaries, joint ventures, license and distribution partnership agreements.

In June 2017 he was appointed Chief Executive Officer of Bracco Imaging S.p.A.

He is a member of the Presidential Committee of Federchimica, – the Italian Federation of the chemical industry – of the BoD of the American Chamber of Commerce in Italy and of the BoD of Endeavor Italy.

In addition he is member of the BoD of Bracco S.p.A. and Centro Diagnostico Italiano.

He is married with two sons

Chief Executive Officer

Jonathan Allis

Jonathan Allis is the founding CEO of Blue Earth Diagnostics. Prior to this role, Jonathan was the General Manager for PET at GE Healthcare Life Sciences, and had global responsibility for GE Healthcare’s PET agent and PET synthesis platforms business. He has previously held positions in R&D, Marketing and Product Development at GE Healthcare, Amersham plc, Siemens Medical Solutions and Oxford Magnet Technology, in the UK, USA and Germany.

Jonathan is co-chair of the Society of Nuclear Medicine and Molecular Imaging Value Initiative Industry Alliance for 2018 – 2019.

Jonathan has an undergraduate degree in Physics from the University of Cape Town and a doctorate in Biochemistry from the University of Oxford.